Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-09-16

Clinical Trial Update: Azithromycin Plus Chloroquine Versus Mefloquine In the Treatment of Uncomplicated P. Falciparum Malaria. [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing azithromycin plus chloroquine versus mefloquine for uncomplicated Plasmodium falciparum malaria has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chloroquine (chloroquine)
  • Mefloquine (Mefloquine)
  • Zithromax (azithromycin) (azithromycin)

Snippet

Sponsor: Pfizer | Conditions: Malaria | Phase 3 | Status: COMPLETED